XML 56 R72.htm IDEA: XBRL DOCUMENT v2.4.0.6
LONG-TERM EQUITY-BASED COMPENSATION PROGRAM (Details) (USD $)
3 Months Ended 12 Months Ended
Mar. 31, 2012
Jun. 30, 2011
Mar. 31, 2011
Jun. 30, 2010
Mar. 31, 2010
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2012
Exercise Price 7.68 [Member]
Dec. 31, 2012
Exercise Price 8.27 [Member]
Dec. 31, 2012
Exercise Price 15.86 [Member]
Dec. 31, 2012
Exercise Price 16.05 [Member]
Dec. 31, 2012
Exercise Price 16.57 [Member]
Dec. 31, 2012
Exercise Price 17.01 [Member]
Dec. 31, 2012
Exercise Price 17.49 [Member]
Dec. 31, 2012
Exercise Price 18.69 [Member]
Dec. 31, 2012
Options/SARs [Member]
Bennett Jones [Member]
Dec. 31, 2011
Options/SARs [Member]
Bennett Jones [Member]
Dec. 31, 2010
Options/SARs [Member]
Bennett Jones [Member]
Dec. 31, 2012
Options/SARs [Member]
Management [Member]
Dec. 31, 2011
Options/SARs [Member]
Management [Member]
Dec. 31, 2010
Options/SARs [Member]
Management [Member]
Dec. 31, 2012
2006 Omnibus Plan [Member]
Dec. 31, 2006
2006 Omnibus Plan [Member]
Dec. 31, 2012
2009 Long-Term Equity-Based Compensation Program [Member]
Options/SARs [Member]
Dec. 31, 2010
2009 Long-Term Equity-Based Compensation Program [Member]
Options/SARs [Member]
Dec. 31, 2009
2009 Long-Term Equity-Based Compensation Program [Member]
Options/SARs [Member]
Dec. 31, 2009
2009 Long-Term Equity-Based Compensation Program [Member]
Options/SARs [Member]
Non-management Directors [Member]
Dec. 31, 2012
2010 Long-Term Equity-Based Compensation Program [Member]
Options/SARs [Member]
Dec. 31, 2011
2010 Long-Term Equity-Based Compensation Program [Member]
Options/SARs [Member]
Dec. 31, 2010
2010 Long-Term Equity-Based Compensation Program [Member]
Options/SARs [Member]
Dec. 31, 2010
2010 Long-Term Equity-Based Compensation Program [Member]
Options/SARs [Member]
Non-management Directors [Member]
Dec. 31, 2012
2011 Long-Term Equity-Based Compensation Program [Member]
Options/SARs [Member]
Dec. 31, 2011
2011 Long-Term Equity-Based Compensation Program [Member]
Options/SARs [Member]
Dec. 31, 2011
2011 Long-Term Equity-Based Compensation Program [Member]
Options/SARs [Member]
Non-management Directors [Member]
Dec. 31, 2012
2012 Long-Term Equity-Based Compensation Program [Member]
Options/SARs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                                                          
Reverse stock split before amendment                 one-for-five reverse                                                        
Stock split after amendment             two-for-one                                                            
Class A common stock reserved for issuance (in shares)                                               1,600,000                          
Share based compensation award maximum number of shares per employee (in shares)                                               80,000                          
Maximum aggregate paying amount of cash and other property other than shares per employee                                               $ 2,000,000                          
Proportion of options/SARs become exercisable on first anniversary of the approval date (in hundredths)                                               33.00%               33.00%     33.00%   33.00%
Proportion of options/SARs become exercisable on second anniversary of the approval date (in hundredths)                                               33.00%               33.00%     33.00%   33.00%
Proportion of options/SARs become exercisable on third anniversary of the approval date (in hundredths)                                                 33.00%             33.00%     33.00%   33.00%
Vested award options annually incremental exercise price expire period from approval date                                               5 years                          
Aggregate maximum number of options/SARs granted to all participants (in shares)                                                   64,000   190,000 8,000 80,000   192,500 10,000 70,000 170,500 10,000 198,000
Exercise price of options/SARs granted to all participants (in dollars per share)           $ 17.01 $ 18.33 $ 16.07                                   $ 8.27   $ 7.68   $ 16.57   $ 15.86   $ 17.49 $ 18.69   $ 17.01
Proportion of options/SARs grants become exercisable (in hundredths)                                                     20.00%         18.20%     20.00%   20.00%
Proportion of remaining options/SARs become exercisable (in hundredths)                                                     75.00%       36.40%            
Number of non-management directors                                                         8     8       7  
Options / SARs                                                                          
Outstanding at beginning of period (in shares) 564,666   531,168   318,000 564,666 531,168 318,000                                                          
Granted (in shares)           198,000 240,500 272,500                                                          
Exercised (in shares)           0 (34,338) (8,000)                                                          
Expired or cancelled (in shares)           0 (122,500) (38,000)                                                          
Forfeited (in shares)           (126,500) (50,164) (13,332)                                                          
Outstanding at end of period (in shares)           636,166 564,666 531,168 318,000                                                        
Options exercisable at end of period (in shares)           323,020 187,018 106,706                                                          
Weighted average remaining contractual term, outstanding           2 years 7 months 6 days 3 years 2 months 12 days 3 years 7 months 6 days                                                          
Weighted average remaining contractual term, exercisable           1 year 8 months 12 days 2 years 3 months 18 days 3 years                                                          
Aggregate intrinsic value, outstanding           0 0 1,702,000                                                          
Aggregate intrinsic value, exercisable           0 509,000 546,000                                                          
Weighted Average Exercise Price                                                                          
Outstanding at beginning of period (in dollars per share) $ 14.91   $ 13.06   $ 9.48 $ 14.91 $ 13.06 $ 9.48                                                          
Granted (in dollars per share)           $ 17.01 $ 18.33 $ 16.07                                   $ 8.27   $ 7.68   $ 16.57   $ 15.86   $ 17.49 $ 18.69   $ 17.01
Exercised (in dollars per share)           $ 0 $ 8.24 $ 7.68                                                          
Expired or cancelled (in dollars per share)           $ 0 $ 15.86 $ 7.68                                                          
Forfeited (in dollars per share)           $ 16.19 $ 13.98 $ 7.68                                                          
Outstanding at end of period (in dollars per share)           $ 15.31 $ 14.91 $ 13.06 $ 9.48                                                        
Options exercisable at end of period (in dollars per share)           $ 13.26 $ 12.17 $ 11.15                                                          
Shares [Abstract]                                                                          
Nonvested at beginning of period (in shares) 377,648         377,648                                                              
Granted (in shares)           198,000                                                              
Vested (in shares)           (178,335)                                                              
Expired or cancelled (in shares)           0                                                              
Forfeited (in shares)           (84,167)                                                              
Nonvested at end of period (in shares)           313,146 377,648                                                            
Weighted Average Grant Date Fair Value [Abstract]                                                                          
Nonvested at beginning of period (in dollars per share) $ 5.56         $ 5.56                                                              
Granted (in dollars per share)           $ 7.08                                                              
Vested (in dollars per share)           $ 7.70                                                              
Expired or cancelled (in dollars per share)           $ 7.70                                                              
Forfeited (in dollars per share)           $ 8.09                                                              
Nonvested at end of period (in dollars per share)           $ 8.24 $ 5.56                                                            
Options outstanding and exercisable exercise price [Line Items]                                                                          
Outstanding at end of period (in shares)           636,166       74,666 56,000 40,000 56,000 70,000 148,500 70,000 121,000                                        
Weighted average remaining contractual term, outstanding           2 years 7 months 6 days       1 year 2 months 12 days 1 year 3 months 18 days 2 years 2 months 12 days 3 months 18 days 2 years 3 months 18 days 4 years 2 months 12 days 3 years 3 months 18 days 3 years 2 months 12 days                                        
Weighted average exercise price, outstanding (in dollars per share)           $ 41.43       $ 7.68 $ 8.27 $ 15.86 $ 16.05 $ 16.57 $ 17.01 $ 17.49 $ 18.69                                        
Options exercisable at end of period (in shares)           323,020       74,666 56,000 26,004 56,000 46,676 0 23,338 40,336                                        
Weighted average exercise price, exercisable (in dollars per share)           $ 13.26       $ 7.68 $ 8.27 $ 15.86 $ 16.05 $ 16.57 $ 17.01 $ 17.49 $ 18.69                                        
Effect of grant of options SARs on the number of diluted shares           80,000 80,000                                                            
Compensation expense related to options/SARs                                   500,000 500,000 400,000 300,000 700,000 300,000                            
Cash received related to the exercise of options/SARs             300,000                                                            
Exercised options/SARs intrinsic value             300,000                                                            
Unrecognized compensation cost related to options/SARs           $ 1,000,000 $ 2,200,000                                                            
Weighted average period over cost expected to recognized           1 year 2 months 12 days 1 year 6 months                                                            
Forfeiture rate of options/SARs awarded (in hundredths)           0.00%                                                              
Fair value of options/SARs estimated at date of grant using weighted average assumptions [Abstract]                                                                          
Expected life from grant date 5 years 5 years 5 years 5 years 5 years                                                                
Risk-free interest rate (in hundredths) 1.11% 1.88% 2.21% 2.13% 2.33%                                                                
Volatility (in hundredths) 55.52% 57.68% 58.63% 62.60% 63.70%                                                                
Dividend yield (in hundredths) 0.00% 0.00% 0.00% 0.00% 0.00%                                                                
Weighted average fair value (in dollars per share) $ 7.08 $ 8.87 $ 9.69 $ 8.99 $ 8.74